Journal Club #2 - The RESTART Trial with Professor Rustam Salman

Thank you to Prof. Rustam Salman for speaking to us about the RESTART trial, which compared starting versus avoiding antiplatelet therapy for adults surviving antithrombotic-associated ICH.

This was NANSIG's second journal club - we thank you for tuning in live or through this catch-up format, and hope you'll join us for more discussions!

Please like and subscribe to our channel for more content. Thank you!

Видео Journal Club #2 - The RESTART Trial with Professor Rustam Salman канала NANSIG